German news magazine Der Spiegel recently interviewed Harvard's Professor Jeffrey Miron on legalization.

In the piece, Miron estimated that the US "could save $85 billion to $90 billion per year" if it legalized drugs. Miron also said:

"If you believe in anything that the Americans claim to believe in -- freedom, individuality, personal responsibility -- you have to legalize drugs. The maxim should be that you're allowed to do it if you're not harming anyone else. There is an assumption that you're harming someone when you take drugs, but the scientific data doesn't support this hypothesis."

The Norwegian government is considering a proposal to decriminalize the smoking of heroin as a harm reduction move to reduce the rate of overdose. Agence France-Presse reported on March 1, 2013, that:

The move would make smoking heroin an offense on par with injecting it, which is illegal in Norway but tolerated.

Oslo's municipality already operates a site where heroin addicts can inject drugs under safer, more hygienic circumstances than they would have had access to otherwise.

"The number of fatal overdoses is too high and I would say it's shameful for Norway," Health Minister Jonas Gahr Stoere told daily Dagsavisen.

Over 750 people from across the world attended the two hour memorial service via social media for activist Kevin Zeese, who suddenly passed away in his sleep on Sept. 6, 2020 at the age of 64.

Activists and friends described aspects and contributions of his exceptional life and contributions to a variety of reform movements.

Sadly we report on the premature death of our beloved co-founder, Kevin B. Zeese. Kevin passed away on Sept. 5, 2020.

Kevin was one of the nation's foremost authorities on drug policy issues. He worked on a wide array of drug related issues since he graduated from George Washington University Law School in 1980.

We are sad to report that the co-founder and President of Common Sense for Drug Policy, Kevin B. Zeese, passed away on September Fifth, 2020. He is sorely missed.

Kevin was one of the nation's foremost authorities on drug policy issues. He worked on a wide array of drug related issues since he graduated from George Washington University Law School in 1980.